ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

In Brief: Candlelight Vigil At Lincoln Memorial Planned For Night Before Cancer March

March 6, 1998

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”

May 6, 2011

GAO Report Refutes Charges Against Control Program

May 30, 1980